A Growing Market With Uneven Practices
Telehealth GLP-1 programs have proliferated rapidly. Where a few years ago there were a handful of direct-to-consumer platforms connecting patients with licensed prescribers for weight loss medications, there are now dozens — offering compounded semaglutide, compounded tirzepatide, and brand-name alternatives through online intake flows, asynchronous questionnaires, and virtual provider consultations. The market has grown to meet genuine demand, and for many patients, these platforms have been the only realistic pathway to a medication that meaningfully improves their health.
That is worth stating plainly at the outset: most GLP-1 telehealth platforms are legitimate businesses. They connect patients with licensed prescribers. They work with licensed compounding pharmacies. They provide real medications to real patients who need them. The fact that this guide focuses on red flags, bad practices, and fraud patterns should not be read as a condemnation of the category. For a large number of patients, telehealth GLP-1 programs represent a genuine and appropriate access pathway to care they could not otherwise obtain.
The problem is the minority. And the second problem is that patients often cannot tell the difference in advance.
Patients signing up for GLP-1 programs are often in a position of genuine vulnerability: they’ve struggled with weight for years, they’re excited about a drug that actually works, and the onboarding process moves fast. That combination creates conditions for exploitation.
Community monitoring of consumer complaints in recent weeks has surfaced patterns that are difficult to dismiss: charges continuing after confirmed cancellation, difficulty reaching customer service after a dispute, automatic enrollment in higher-tier plans without clear consent, and abrupt program terminations leaving patients mid-titration with no clear path forward. These complaints span multiple platforms and describe consistent patterns, not isolated incidents.
Patients navigating this market have had no neutral resource for vetting providers, understanding their rights, or knowing what to do when something goes wrong. This guide attempts to fill that gap. It is written from the perspective of a California attorney whose practice touches consumer protection, and it is designed to be practically useful: here is what to ask, here is what to look for, here is what you can do.
This guide is for patients who are considering enrolling in a GLP-1 telehealth program and want to evaluate it carefully before signing up, as well as patients who are already enrolled and have questions about their rights, billing practices, or how to cancel. It is also useful for patients who have experienced billing problems and want to understand their options.
Before You Sign Up: Questions to Ask
A legitimate telehealth GLP-1 platform should be able to answer every question on this list before you provide payment information. If a platform is evasive, unable to provide specific answers, or routes you to a sales process instead of a direct answer, that pattern is informative.
About the Prescription and Medical Oversight
-
Who is the prescribing provider — physician, NP, or PA? All three can lawfully prescribe in most states, but you should know which. Ask for the prescriber’s name and their state license number. You can verify licenses through your state medical board’s public lookup tool.
-
Is the initial consultation synchronous (live video) or asynchronous (questionnaire only)? A questionnaire-only intake — in which a provider reviews your submitted responses and signs a prescription without speaking with you — is a lower standard of care. It is not necessarily unlawful, but it is a meaningful quality distinction.
-
Who manages dose adjustments and follow-up? GLP-1 medications involve a titration schedule. Ask specifically: who decides when your dose increases, and how does that process work? Is there a provider review, or is it automatic?
-
What happens if I have a side effect or medical question between shipments? Ask for specifics: is there a phone line, a messaging portal, a nurse line? What is the response time commitment? “Contact us through our portal” is a different answer from “you can reach a provider within 24 hours.”
About the Pharmacy
-
Which pharmacy compounds and ships my medication? A legitimate program should be able to name their pharmacy partner or partners. “We work with licensed pharmacies” without naming them is evasion.
-
Is that pharmacy 503A or 503B accredited? 503A pharmacies compound on a patient-specific basis; 503B outsourcing facilities can compound in bulk for distribution. Both operate under FDA-regulated frameworks. Asking this question signals that you understand the distinction and expect a real answer.
-
Can I get a Certificate of Analysis for my medication lot? A CoA is a third-party lab test result verifying potency, purity, and the absence of contaminants for a specific compounding batch. A legitimate compounding program should be able to provide this on request. Inability to do so is a meaningful concern.
-
Will you notify me if you change pharmacy partners? Pharmacy switching without notice — which means a change in who compounded your medication, under what standards, in what facility — has been reported by patients of multiple platforms. Ask upfront whether this can happen and whether you’ll be informed.
About Pricing and Billing
-
What exactly is included in the monthly fee? Ask them to enumerate: medication, shipping, provider consultations, supplies (syringes, alcohol wipes), follow-up visits, dose adjustments. Hidden fees for items not included in the advertised price are a common complaint.
-
Is pricing locked in, or can it change? Some platforms advertise introductory pricing that increases after the first shipment or after a promotional period. Ask specifically whether the price you see is the price going forward.
-
Are there enrollment fees, cancellation fees, or early termination charges? Some programs have minimum commitment periods or charge a fee to cancel. Get these terms in writing before you enroll.
-
What is the cancellation policy — exactly, in writing? “Cancel anytime” means nothing without specifics. Ask: how do I cancel, how much notice is required, what is the last date I can cancel to avoid the next charge?
-
Do you auto-renew? If so, how and when am I notified? FTC regulations require clear disclosure of auto-renewal terms before enrollment. Ask how you will be reminded before each renewal charge.
-
What payment methods are accepted? If you have a choice, pay with a credit card rather than a debit card. Credit cards provide substantially stronger dispute rights under the Fair Credit Billing Act (FCBA) if unauthorized charges occur after cancellation. See Section 6.
About the Medication
-
What compound am I receiving — semaglutide base, sodium salt, or acetate form? The form of the active pharmaceutical ingredient matters and is a subject of ongoing regulatory discussion. You have a right to know what you are being prescribed.
-
What are the added ingredients (B12, etc.) and why? Many compounded GLP-1 formulations include B12 or other additives. Ask what they are and what clinical purpose they serve.
-
What dose will I start at, and how does titration work? Get the starting dose and the titration schedule in writing. If the titration is described only vaguely (“we’ll adjust as needed”), ask for specifics.
-
What is the maximum dose available through this program? Some platforms only support lower doses. If you anticipate needing higher titration doses, confirm they are available before committing to a program.
Red Flags Before You Enroll
The following are warning signs that warrant either additional scrutiny or walking away entirely. None of them are individually conclusive — some legitimate platforms may have one of these characteristics for legitimate reasons. But any one of them should prompt more questions, and multiple together should be treated as a serious warning.
-
No physical business address listed anywhere on the site. Legitimate telehealth platforms and the pharmacies they work with have verifiable physical addresses. An absence of any business address — only a contact form or P.O. box — is a meaningful concern. The pharmacy filling your prescription is legally required to be licensed and identifiable.
-
Pricing that seems dramatically below market rate. Compounded GLP-1 programs operating at $100/month or below should prompt serious questions about what is actually in the vial, under what conditions it was compounded, and what quality controls apply. The cost of raw active pharmaceutical ingredient, proper compounding, sterility testing, and shipping creates a floor below which legitimate programs cannot sustainably operate.
-
No information about which pharmacy fulfills orders. If a platform cannot or will not name the pharmacy compounding your medication, you have no way to verify the pharmacy’s licensure, accreditation, or track record. This is not a minor omission.
-
High-pressure enrollment tactics — countdown timers, “today only” pricing, urgency language. Legitimate medical programs do not use conversion optimization tactics borrowed from e-commerce. Pressure to enroll immediately before you have reviewed all terms is a consumer protection concern.
-
Questionnaire-only “consultation” with no live provider interaction. Receiving a prescription for a potent injectable medication following only a written questionnaire — with no synchronous interaction with a provider — is a quality concern. A provider who has never spoken with you has limited ability to assess your history, manage drug interactions, or respond to concerns.
-
No clear, published cancellation policy — or one buried in multi-page fine print. The cancellation policy should be easy to find, easy to read, and specific. If you cannot find it with a reasonable search, or if it requires parsing dense terms-of-service language, that obscurity is intentional and informative.
-
No Certificate of Analysis available on request. If the platform or its pharmacy cannot produce a CoA for your medication lot, ask why. No CoA means no third-party verification of potency, purity, or sterility. This is not an unreasonable request — it is basic quality accountability.
-
Vague or evasive compound descriptions. “Proprietary blend,” no disclosure of added ingredients, no clear dosing information, or inconsistent descriptions of what is in the vial are red flags. You have a right to know exactly what you are being prescribed and why.
-
Social media-only presence — no .com domain, no verifiable business registration, operates through Instagram or Telegram. A legitimate telehealth platform operates as a registered business with a real website, a real address, and verifiable licensing. Platforms operating exclusively through social media channels or messaging apps have no accountability infrastructure.
Billing Fraud: What’s Being Reported
Community monitoring of consumer reports in recent weeks has surfaced a consistent pattern across multiple platforms that warrants being named directly, even without the ability to make legal findings about specific companies.
Patient cancels subscription → receives written confirmation of cancellation → charge appears on their card anyway → customer service is unresponsive, slow to respond, or disputes the validity of the cancellation → charge repeats the following month → patient files a credit card dispute.
This pattern has been described in consumer reports related to multiple named telehealth GLP-1 platforms. The specifics vary — some platforms appear to have disputed whether the cancellation was processed correctly; others have claimed the charge was for medication already shipped; still others have been unresponsive entirely. What is consistent across reports is the structure: a confirmed cancellation followed by unauthorized charges, followed by difficulty obtaining resolution.
Related patterns that have also been reported include:
- Automatic enrollment in higher-tier plans without clear consent — patients who enrolled in a standard program finding themselves charged for a “premium” tier without explicitly selecting it
- Charges continuing 60–90 days after cancellation, sometimes well past the point at which any good-faith shipping or processing delay could explain them
- Abrupt program termination without refund, leaving patients mid-titration without continued care or a clear path to transition to another provider
- Billing for medication that was never shipped or that was stopped without the patient’s knowledge
If these patterns occur as described, they constitute unauthorized billing — a consumer protection violation under the laws of every state, and potentially a federal violation under FTC regulations governing negative option and subscription services. A company that charges a customer after confirmed cancellation, regardless of the reason offered, has engaged in an unauthorized transaction. The customer has a right to dispute it and to seek remedies.
The description of these patterns as “reported” reflects the limits of what this guide can establish independently. Community reports are not legal findings. The existence of complaints does not establish legal liability. But the volume and consistency of the pattern across multiple platforms and multiple reporting sources warrants treating it as a real risk that patients should prepare for.
The practical implication for patients is this: even with a legitimate platform, the safest approach is to treat the cancellation process as adversarial until confirmed and to document every step. Section 5 describes how to do that.
Section 5How to Cancel Safely
The following steps create a documented record that protects your ability to dispute any charges that appear after cancellation. Follow them even if you expect no problems. The value of documentation is that you only know you needed it after the fact.
-
1
Cancel in writing, by email — not by phone. A phone cancellation leaves no paper trail. An email creates a timestamped record of when you requested cancellation, what you said, and who received it. Use the email address listed in your account or on the platform’s contact page. In the email, state explicitly: “I am requesting cancellation of my account and subscription, effective immediately. Please confirm cancellation in writing.”
-
2
Request written confirmation and save it. Follow up if you do not receive a written confirmation within 24–48 hours. “Please confirm my cancellation in writing with a confirmation number or account status update.” Save the confirmation email. If you receive a confirmation through the platform’s portal rather than email, screenshot it with the date visible.
-
3
Screenshot your account status before and after cancellation. Log into your account and take a screenshot showing your current subscription status. After you receive cancellation confirmation, take another screenshot showing any “canceled,” “inactive,” or “terminated” status. Include the date and time in the screenshot if possible (visible in your browser or system clock).
-
4
Note the date and your billing cycle. Write down: the date you canceled, where you were in the billing cycle, and when the next charge was scheduled to occur. This tells you what the last legitimate charge should be and when any charge thereafter is unauthorized.
-
5
Monitor your card for 60–90 days after cancellation. Most unauthorized post-cancellation charges appear within the first billing cycle, but some platforms have generated reports of charges two or three months after cancellation. Set a calendar reminder to review your statements.
-
6
If a charge appears after cancellation, act immediately. Do not wait to see if it resolves. Contact the platform directly in writing, referencing your cancellation confirmation date and the unauthorized charge date and amount. Simultaneously, initiate a dispute with your credit card issuer. Do not wait on the platform’s response before starting the dispute process — FCBA dispute windows are time-limited.
Some platforms route cancellation through an in-app flow rather than email. If you cancel through the app, supplement it: also send an email to the support address stating that you have canceled through the app and requesting written confirmation. This creates an email record regardless of what the app shows.
How to Dispute Unauthorized Charges
Credit Card Disputes (FCBA)
The Fair Credit Billing Act (FCBA) gives you the right to dispute unauthorized or incorrect charges on your credit card. This is one of the most powerful consumer protection tools available to you in a billing dispute with a telehealth platform.
-
Act within 60 days of the statement containing the charge. The FCBA requires you to notify your card issuer within 60 days of the date of the statement on which the disputed charge first appears. Do not delay.
-
Contact your card issuer in writing. Call the number on the back of your card to report the dispute, but also confirm it in writing. Many issuers have online dispute portals; use them and save the confirmation.
-
The issuer must investigate and provisionally credit your account. Under the FCBA, your card issuer must acknowledge your dispute within 30 days and resolve it within two billing cycles (not to exceed 90 days). They are required to credit your account during the investigation period.
-
Provide documentation. Your written cancellation email, confirmation of cancellation, account status screenshots, and card statements showing the charges are your evidence. Organize them before you call.
Debit Card Disputes (EFTA)
Debit card disputes are governed by the Electronic Fund Transfer Act (EFTA), which provides meaningfully weaker protections than the FCBA. You have dispute rights, but the time windows are shorter, the process is more burdensome, and provisional crediting is not automatic in the same way. This is why, as a practical matter, using a credit card for recurring subscription services is strongly advisable: it gives you more leverage if something goes wrong.
Documentation to Gather Before Disputing
- Written cancellation confirmation from the platform (email or screenshot)
- Screenshots of your account showing canceled/inactive status
- Copies of all email or chat communication with the platform
- Card statements showing the unauthorized charges with dates and amounts
- Any written terms of service or cancellation policy you accepted at enrollment
- Notes from any phone calls: date, time, name of representative, what was said
If the Platform Is Unresponsive
If the telehealth platform does not respond to your cancellation or dispute requests within a reasonable period (5–7 business days), escalate simultaneously on multiple fronts:
- File a complaint with your state Attorney General’s consumer protection division. Every state has one. A complaint creates a record and may prompt the AG’s office to investigate if they are receiving similar complaints from other patients.
- File a complaint with the FTC at reportfraud.ftc.gov. The FTC uses complaint data to identify patterns and prioritize enforcement actions. Individual complaints may not generate immediate individual relief, but they contribute to enforcement visibility.
- File a complaint with your state’s medical board if the prescribing provider is unresponsive to medical concerns (not just billing) or if you believe your care was abandoned without appropriate transition.
- File a BBB complaint. Less formal, but a visible public record that may prompt a response from the platform and creates documentation.
A chargeback is a process initiated by your card issuer to reverse a transaction at the network level. It is distinct from a dispute in that the issuer, not you, initiates the reversal. When you file a dispute, your issuer may initiate a chargeback as part of the resolution process. Chargebacks have implications for your relationship with the merchant (they may close your account or add you to a watchlist) but that is the merchant’s prerogative — your right to dispute unauthorized charges does not disappear because the merchant may respond adversely. Your card issuer handles the mechanics; your job is to provide documentation and let the process run.
Your Rights as a Telehealth Patient
Patients often underestimate the rights they have in a telehealth relationship. The online interface and subscription model can create an impression that the platform controls the terms of your care. It does not, entirely. Your rights as a patient do not disappear because your provider works through an app.
-
You have the right to know who is prescribing your medication and their license number. Your prescribing provider must be licensed in your state. You can verify their license through your state medical board’s public lookup tool.
-
You have the right to request your medical records. Under HIPAA and most state laws, you have the right to obtain copies of your medical records, including your prescription history and any records of consultations with the platform’s providers. The platform cannot deny this.
-
You have the right to transfer your prescription to another pharmacy. A valid prescription can generally be filled at any pharmacy licensed in your state, not just the one the telehealth platform has designated. If you want to transfer your care, ask for your prescription in writing.
-
You have the right to know what compound you are receiving and what is in it. Your prescription should identify the active pharmaceutical ingredient, its form, concentration, and any added ingredients. If you cannot find this information on your prescription or in your platform account, ask.
-
Telehealth platforms cannot prescribe medications in states where they are not licensed to operate. If you have reason to believe your prescription was issued by a provider who is not licensed in your state, that is a serious concern you can raise with your state medical board.
-
Compounding pharmacies must be licensed in the state where they ship. A pharmacy compounding medications and shipping them to you in your state must be licensed by your state pharmacy board. You can verify this through your state board’s public license lookup.
-
You have the right to a Certificate of Analysis for your medication lot. While not every patient exercises this right, it exists. A CoA verifies that the compound in your vial has been tested for potency, purity, and sterility. You can request it from the pharmacy directly, or ask the platform to provide it.
Platforms Worth Comparing vs. Avoiding: A Framework
This guide does not name specific platforms as categorically good or bad. The reasons are practical: the landscape changes quickly, companies improve or deteriorate, and making definitive evaluations of specific businesses based on community reports rather than independent investigation would be misleading. What this guide can offer is a framework for doing your own research.
- Search the FTC complaint database. Go to reportfraud.ftc.gov and search the platform name. The FTC’s Consumer Sentinel database is also available to attorneys and investigators, but the public report portal shows whether complaints exist.
- Search your state AG’s consumer complaint records. Many state Attorneys General publish consumer complaint data. Search “[your state] attorney general consumer complaint [platform name].”
- Search “[platform name] BBB complaints.” Better Business Bureau complaint records are publicly searchable. Look at both the number of complaints and how the company responded to them.
- Search “[platform name] Reddit.” Patient communities on Reddit (/r/semaglutide, /r/Ozempic, /r/tirzepatide, and related communities) provide real-time consumer experience reports that are not filtered through the platform’s marketing. Read both positive and negative reports critically.
- Verify the pharmacy on your state board’s license lookup. Once you know which pharmacy the platform uses, verify it is licensed in your state at your state pharmacy board’s public lookup tool.
Signals That Favor a Platform
- Names its pharmacy partner upfront, before enrollment, without requiring you to ask
- Provides Certificates of Analysis on request, or publishes them publicly
- Has a clearly written, easy-to-find cancellation policy stating exactly how and when to cancel
- Has verifiable physical business address and registered business information
- Offers synchronous (live video or phone) provider consultations, not just questionnaire intake
- Has responsive customer service with a direct contact method beyond a web form
- Shows a pattern of resolving consumer complaints in BBB and community records
Signals That Counsel Caution
- Multiple recent BBB complaints or FTC reports describing the post-cancellation billing pattern
- Community reports describing unresponsive customer service during billing disputes
- Pricing that cannot be explained by legitimate compounding costs and overhead
- Difficulty finding their cancellation policy or getting a straight answer about it
- No information about their pharmacy partner anywhere on the site
- High-volume marketing with limited substantive information about program structure
The Regulatory Gap
Understanding why this problem exists requires understanding a structural feature of how telehealth GLP-1 platforms are regulated — or more precisely, how they are not regulated as businesses.
The clinical practice of the prescribing providers is regulated by state medical boards. The compounding pharmacy is regulated by state pharmacy boards and, for 503B outsourcing facilities, by the FDA. But the platform itself — the business model, the subscription structure, the billing practices, the customer service operations — does not fall under a single regulatory body with clear authority and active oversight.
The FTC has authority over deceptive practices and unfair business methods, including violations of its Negative Option Rule governing subscription services and automatic renewals. That authority clearly applies to the billing practices described in this guide. But FTC enforcement is reactive: it responds to patterns of harm after complaints accumulate, not prospectively to individual consumer problems. Enforcement actions take years. Individual patients need remedies in weeks.
State Attorneys General have consumer protection authority that in many states is quite broad, including the ability to investigate individual companies, demand restitution, and impose civil penalties. But AG offices have limited bandwidth, and telehealth platforms operate across state lines in ways that complicate jurisdiction.
The practical result is that patients are largely self-protected through due diligence. There is no regulatory body actively vetting GLP-1 telehealth platforms before they take your money. The framework exists; the proactive enforcement largely does not. This guide exists because that gap is real and its consequences fall on patients.
This is not a counsel of despair. The dispute rights available under the FCBA are real and effective. State AG complaint processes create accountability over time. Community knowledge-sharing allows patients to identify problem platforms before enrolling. And the platforms that operate honestly have nothing to fear from patients who ask questions and read their cancellation policies.
The regulatory gap means you cannot rely on a government agency to vet your telehealth provider before you sign up. It means the due diligence responsibility rests primarily with you. And it means that the single most practical step you can take — beyond the questions in Section 2 — is to use a credit card, keep your cancellation documentation, and know your dispute rights before you need them.
Section 10Frequently Asked Questions
How do I know if a GLP-1 telehealth platform is legitimate?
Legitimate GLP-1 telehealth platforms will clearly identify the pharmacy that compounds and ships your medication, name the licensed providers who prescribe, publish a specific cancellation policy, and be able to provide a Certificate of Analysis for medication lots on request. Check the platform name against the FTC complaint database, your state Attorney General’s consumer protection database, and search “[platform name] BBB complaints” and “[platform name] Reddit” before enrolling. The inability or unwillingness to answer basic questions about prescribing, pharmacy accreditation, or cancellation terms is itself a meaningful signal.
What should I do if a telehealth company charges me after I canceled?
First, attempt to resolve directly with the platform using written communication — email, not phone — citing your cancellation confirmation date and the specific charge date. If you do not receive a refund within a reasonable period (5–7 business days), dispute the charge with your credit card issuer under the Fair Credit Billing Act (FCBA). You have 60 days from the statement containing the unauthorized charge to initiate a dispute. Provide your written cancellation confirmation and account screenshots as documentation. Simultaneously, file a complaint with your state Attorney General’s consumer protection division and the FTC at reportfraud.ftc.gov. Document everything in writing.
What is the safest way to cancel a GLP-1 telehealth subscription?
Cancel in writing via email — not by phone — to create a timestamped record. Explicitly request written confirmation of your cancellation. Take screenshots of your account status both before and after canceling, capturing any “canceled” or “inactive” designation. Note the exact date and where you are in the billing cycle so you can identify the last legitimate charge. Then monitor your card for 60–90 days after cancellation and act immediately if a charge appears. If the platform is unresponsive, dispute with your card issuer and file complaints with your state AG and the FTC.
Do I have the right to know which pharmacy fills my GLP-1 prescription?
Yes. You have the right to know which pharmacy compounds and dispenses your medication, including the pharmacy’s name, state license number, and whether it operates under 503A or 503B accreditation. A legitimate compounding program should be able to answer these questions directly and provide a Certificate of Analysis for your medication lot on request. Any platform that cannot or will not identify its pharmacy partner is operating in a way that should raise concern. You also have the right to request your prescription and have it filled at a pharmacy of your choosing.
What are the warning signs of a fraudulent GLP-1 program?
Key warning signs include: no physical business address listed anywhere on the site; pricing dramatically below market (below $100/month for a GLP-1 medication program warrants scrutiny); refusal to name the fulfilling pharmacy; high-pressure enrollment tactics including countdown timers and “today only” pricing; questionnaire-only consultations with no live provider interaction; a cancellation policy that is absent, buried in fine print, or difficult to locate; inability to provide a Certificate of Analysis; vague descriptions of the compound’s ingredients and form; and operations primarily through social media with no verifiable business presence.